Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-01-26

FDA Approved: ALLERGY RELIEF — Supplemental Application (Prodose, Inc)

View source ↗

Summary

The FDA approved a supplemental application for Allergy Relief containing cetirizine hydrochloride from Prodose, Inc, under ANDA077829.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ALLERGY RELIEF (cetirizine hydrochloride)

Snippet

SUPPL AP for ALLERGY RELIEF (CETIRIZINE HYDROCHLORIDE)